- Home
- HKPD vs CELZ Comparison
HKPD vs CELZ Comparison
Compare HKPD & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKPD | CELZ |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6M | 10.4M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | HKPD | CELZ |
|---|---|---|
| Price | $0.99 | $2.70 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 142.5K | 113.5K |
| Earning Date | 08-14-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,313,818.00 | $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.72 | N/A |
| 52 Week Low | $0.81 | $1.69 |
| 52 Week High | $3.79 | $6.90 |
Technical Indicators
Market Signals| Indicator | HKPD | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 39.69 |
| Support Level | $0.92 | $2.58 |
| Resistance Level | $1.11 | $3.15 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 12.91 | 14.48 |
Price Performance
Historical ComparisonAbout HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.